Phase 3 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The legal representative of the potential participant (such as a parent or guardian) must be willing to give formal written consent for participation in the study.
- The participant must be able to swallow and take medication by mouth.
- The participant must be between 2 and 18 years old at the time of diagnosis.
Who may not be able to join:
- People who have a documented allergic reaction to the type of heart-protective medications used in this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Manal Hamed El-Hamamsy, Prof, Ain Shams University
Phone: +201093942389
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Left Ventricular Ejection Fraction (LVEF)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.